The U.S. Food and Drug Administration (FDA) has announced key developments in healthcare, marking advancements in drug treatment, medical device safety, and hygiene technology. Firstly, the FDA approved Fabhalta (iptacopan) for treating complement 3 glomerulopathy (C3G), a rare kidney disorder.
A significant donation of medical equipment valued at $78.1M has been made to Jamaica's Western Regional Health Authority (WRHA) by the CHASE Fund. This generous contribution promises to improve healthcare services across several hospitals in the region. The handover ceremony was held on March
The global market for Foley catheters is on an impressive growth trajectory, with projections indicating an expansion from USD 2,043.0 million in 2025 to USD 4,125.5 million by 2035. This remarkable growth, reflecting a compound annual growth rate (CAGR) of 7.6%, is a testament to the increasing
The rapid advancement of 3D printing technology, commonly known as additive manufacturing, is significantly impacting the medical device industry by pushing the boundaries of patient care and innovative solutions. With the industry's current value at an impressive $2 billion in 2022 and
Recent trends in medical technology reveal an interesting yet concerning development: the increase in medical device recalls. As innovations flood the healthcare market, the emphasis on patient safety has never been higher. February's recalls, as meticulously recorded by the FDA, provide a
James Maitland is an expert in robotics and IoT applications in medicine, driven by a strong passion for leveraging technology to advance healthcare solutions. Today, we will discuss how smart exercise equipment and health tracking apps may collect and use our personal health data. Can you explain
